West Pharmaceutical Services, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 13G, Stake over 5%, passiveAug 6 →InsidersNo open-market buys. 2 insiders sold $1.1M, 0 of 2 sales on a 10b5-1 plan.→HoldersBlackRock 9.4%Vanguard 6.6%Vanguard Portfolio 5.7%→PeersClosest companies: BIO, ZBH, VREX→
From the filings
Figures
- Revenue
- $3.33Blast 12 months
- Net income
- $564.9Mlast 12 months
- Operating cash flow
- $715.3Mlast 12 months
- Cash and equivalents
- $435.8Mat the last balance sheet
- Total debt
- $202.9Mat the last balance sheet
- Shares outstanding
- 70.4M shareson issue